Business Information
The group's principal activities are to design, develop, manufacture and market orthopedic reconstructive implants, spinal implants, trauma and related orthopaedic surgical products. Orthopedic reconstructive implants restore joint function lost due to trauma in joints. Spinal implants are utilized by orthopaedic surgeons and neurosurgeons in the treatment of degenerative diseases, deformities and trauma in all regions of the spine. Trauma products are devices used primarily to reattach or stabilize damaged bone or tissue to support the body's natural healing process. The products are sold under the brand names nexgen(R), versys(R), zmr(tm) and trilogy(r). The group operates in more than 24 countries and markets its products in more than 80 countries. The operations of the group are carried out in the United States, Europe and Asia-Pacific. The group acquired centerpulse ag and incentive capital ag in 2003. On 23-Apr-2004, it acquired implex corp.
|
|
Name |
Title
|
Email
|
| Bruno Melzi | Chmn. - Europe, Africa, Middle East | N/A | | Raymond Elliott | Chmn. | N/A | | Jon Kramer | Pres. - US Sales | N/A | | Stephen Ooi | Pres. - Asia Pacific | N/A | | Cheryl Blanchard | Sr. VP - Research, Development, Chief Scientific Officer | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 3,495,400 | 834,500 | | 2005 | 3,286,100 | 732,500 | | 2004 | 2,980,900 | 541,800
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
